THROMBOCYTOSIS AS PROGNOSTIC FACTOR FOR SURVIVAL IN PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER TREATED WITH FIRST- LINE CHEMOTHERAPY.
Objective: The aim of this study was to evaluate elevated platelet count as a prognostic factor for survival in patients with advanced (stage IIIB/ IV) non- small cell lung cancer (NSCLC) receiving first- line chemotherapy. Methods: From 2005 to 2009 three hundreds forty seven consecutive patient...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Peytchinski Publishing
2014-12-01
|
| Series: | Journal of IMAB |
| Subjects: | |
| Online Access: | http://www.journal-imab-bg.org/issue-2014/issue6/JofIMAB_2014-20-6p560-564.pdf |